Literature DB >> 27035750

CLDN6-induced apoptosis via regulating ASK1-p38/JNK signaling in breast cancer MCF-7 cells.

Yaxiong Guo1, Dongjing Lin1, Mingzi Zhang1, Xiaowei Zhang1, Yanru Li1, Ruan Yang1, Yan Lu1, Xiangshu Jin1, Minlan Yang1, Miaomiao Wang1, Shuai Zhao1, Chengshi Quan1.   

Abstract

Claudin 6 (CLDN6), a member of tight junction protein claudin (CLDN) family, inhibits proliferation and induces apoptosis of MCF-7 breast cancer cells. However, these molecular mechanisms of CLDN6-induced apoptosis remain largely elusive. We previously found that restoration of human CLDN6 gene expression was correlated with the expression level of apoptosis signal-regulating kinase 1 (ASK1) using cDNA array and bioinformatics analysis. ASK1, a mitogen-activated protein kinase kinase kinase, is involved in environmental stress-activation of the c-jun N-terminal kinase (JNK) and p38 pathways, which contribute to apoptosis-associated tumor cell death. In the present study, we show that the restoration of CLDN6 gene expression in MCF-7 cells marhedly decreased ASK1 phosphorylation at Ser967. Activated ASK1ser967 further induced the activation of downstream targets, JNK and p38 kinase. MCF-7/CLDN6 stable transfection cell clone treated with TRX1, an ASK1 inhibitor, showed suppressed JNK and p38 activation, and showed substantially increased survival and colony formation and reduced percent of apoptotic cells using TUNEL staining and DNA ladder. Furthermore, TRX1 treatment increased Bcl-2/Bax ratio and reduced caspase-3 cleavage in MCF-7/CLDN6 stable transfection cell clone. Therefore, these data show that CLDN6 mediates ASK1-p38/JNK apoptotic signaling in MCF-7 cells, and it is correlated with constitutive deregulation of the balance of Bcl-2 family proteins and activation of caspase-3.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27035750     DOI: 10.3892/ijo.2016.3469

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  15 in total

1.  The expression and the tumor suppressor role of CLDN6 in colon cancer.

Authors:  Huinan Qu; Min Wang; Miaomiao Wang; Yuanyuan Liu; Chengshi Quan
Journal:  Mol Cell Biochem       Date:  2022-06-14       Impact factor: 3.396

2.  CLDN6 enhances chemoresistance to ADM via AF-6/ERKs pathway in TNBC cell line MDAMB231.

Authors:  Minlan Yang; Yanru Li; Yang Ruan; Yan Lu; Dongjing Lin; Yinping Xie; Bing Dong; Qihua Dang; Chengshi Quan
Journal:  Mol Cell Biochem       Date:  2017-11-20       Impact factor: 3.396

3.  Bioinformatic analysis reveals potential properties of human Claudin-6 regulation and functions.

Authors:  Dongjing Lin; Yaxiong Guo; Yanru Li; Yang Ruan; Mingzi Zhang; Xiangshu Jin; Minlan Yang; Yan Lu; Peiye Song; Shuai Zhao; Bing Dong; Yinping Xie; Qihua Dang; Chengshi Quan
Journal:  Oncol Rep       Date:  2017-06-27       Impact factor: 3.906

4.  Lic regulates JNK-mediated cell death in Drosophila.

Authors:  Yihao Sun; Di Zhang; Chenglin Li; Jiuhong Huang; Wenzhe Li; Yu Qiu; Aiwu Mao; Mingcheng Zhou; Lei Xue
Journal:  Cell Prolif       Date:  2019-03-07       Impact factor: 6.831

5.  Quinalizarin induces ROS‑mediated apoptosis via the MAPK, STAT3 and NF‑κB signaling pathways in human breast cancer cells.

Authors:  Yan-Qing Zang; Yan-Yu Feng; Ying-Hua Luo; Yu-Qing Zhai; Xue-Ying Ju; Yu-Chao Feng; Ya-Nan Sheng; Jia-Ru Wang; Chang-Qing Yu; Cheng-Hao Jin
Journal:  Mol Med Rep       Date:  2019-10-02       Impact factor: 2.952

6.  Estrogen receptor β inhibits breast cancer cells migration and invasion through CLDN6-mediated autophagy.

Authors:  Peiye Song; Yanru Li; Yuan Dong; Yingying Liang; Huinan Qu; Da Qi; Yan Lu; Xiangshu Jin; Yantong Guo; Yiyang Jia; Xinqi Wang; Wenhong Xu; Chengshi Quan
Journal:  J Exp Clin Cancer Res       Date:  2019-08-14

7.  Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases.

Authors:  Irene Coati; Gábor Lotz; Giuseppe Nicolò Fanelli; Stefano Brignola; Cristiano Lanza; Rocco Cappellesso; Antonio Pellino; Salvatore Pucciarelli; Gaya Spolverato; Vincenza Guzzardo; Giada Munari; Giovanni Zaninotto; Marco Scarpa; Luca Mastracci; Fabio Farinati; Stefano Realdon; Pierluigi Pilati; Sara Lonardi; Nicola Valeri; Massimo Rugge; Andras Kiss; Fotios Loupakis; Matteo Fassan
Journal:  Br J Cancer       Date:  2019-06-25       Impact factor: 7.640

8.  Arctigenin Enhances the Cytotoxic Effect of Doxorubicin in MDA-MB-231 Breast Cancer Cells.

Authors:  Kyu-Shik Lee; Min-Gu Lee; Yun-Suk Kwon; Kyung-Soo Nam
Journal:  Int J Mol Sci       Date:  2020-04-23       Impact factor: 5.923

9.  CLDN6 promotes chemoresistance through GSTP1 in human breast cancer.

Authors:  Minlan Yang; Yanru Li; Xiangfeng Shen; Yang Ruan; Yan Lu; Xiangshu Jin; Peiye Song; Yantong Guo; Xiaoli Zhang; Huinan Qu; Yijia Shao; Chengshi Quan
Journal:  J Exp Clin Cancer Res       Date:  2017-11-07

10.  Second-generation proteasome inhibitor carfilzomib enhances doxorubicin-induced cytotoxicity and apoptosis in breast cancer cells.

Authors:  Yonghua Shi; Yang Yu; Zhenyu Wang; Hao Wang; Shayahati Bieerkehazhi; Yanling Zhao; Lale Suzuk; Hong Zhang
Journal:  Oncotarget       Date:  2016-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.